Literature DB >> 4530983

Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity.

M D Maines, A Kappas.   

Abstract

Treatment of rats in vivo with cobalt chloride stimulated heme oxidation by hepatic microsomes to levels up to 800% above controls. This treatment also caused increases in liver weight and in total microsomal protein; in contrast, marked decreases were produced in microsomal oxidation of ethylmorphine (80%), and in cytochrome P-450 (60-70%) and heme (30-50%) contents. Cobalt chloride treatment did not affect heme oxidation by the spleen heme oxygenase system. The rate of heme oxidation by hepatic microsomal enzymes and the microsomal content of cytochrome P-450 were found to be unrelated. This conclusion was reached from studies in which microsomal heme oxygenase activity from cobalt-treated animals could be increased by 900% above control levels in the same microsomal preparation in which cytochrome P-450 content was decreased to spectrally unmeasurable amounts after incubation with 4 M urea. The same treatment eliminated ehtylmorphine demethylation and decreased microsomal NADPH-cytochrome c reductase (EC 1.6.2.4) activity by 75%. It is concluded that (i) the hepatic microsomal enzyme system that oxidizes heme compounds is not the same as that which metabolizes drugs, (ii) cytochrome P-450 is not essential for the oxidation of heme by liver cells, (iii) there is no direct relationship between the rate of heme oxidation and the level of NADPH-cytochrome c reductase activity, and (iv) the oxidation of heme is protein-dependent and the active proteins are inducible, but are different from those involved in drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4530983      PMCID: PMC433868          DOI: 10.1073/pnas.71.11.4293

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  The degradation of haem by mammals and its excretion as conjugated bilirubin.

Authors:  G H Lathe
Journal:  Essays Biochem       Date:  1972       Impact factor: 8.000

2.  Microsomal mixed-function oxidations: the metabolism of xenobiotics.

Authors:  H S Mason; J C North; M Vanneste
Journal:  Fed Proc       Date:  1965 Sep-Oct

3.  Microsomal heme oxygenase. Characterization of the enzyme.

Authors:  R Tenhunen; H S Marver; R Schmid
Journal:  J Biol Chem       Date:  1969-12-10       Impact factor: 5.157

4.  The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin.

Authors:  R Tenhunen; H S Marver; R Schmid
Journal:  J Lab Clin Med       Date:  1970-03

5.  Enzymatic degradation of heme. Oxygenative cleavage requiring cytochrome P-450.

Authors:  R Tenhunen; H Marver; N R Pimstone; W F Trager; D Y Cooper; R Schmid
Journal:  Biochemistry       Date:  1972-04-25       Impact factor: 3.162

6.  The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.

Authors:  R Tenhunen; H S Marver; R Schmid
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

7.  Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system.

Authors:  B A Schacter; E B Nelson; H S Marver; B S Masters
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

8.  The formation of biliverdin by chicken macrophages in tissue culture. Observations on the effect of inhibitors.

Authors:  A W Nichol
Journal:  Biochim Biophys Acta       Date:  1970-10-27

9.  The enzymatic conversion of hemoglobin to bilirubin.

Authors:  R Tenhunen; H S Marver; R Schmid
Journal:  Trans Assoc Am Physicians       Date:  1969

10.  The effect of cobalt chloride administration on the synthesis of hepatic microsomal cytochrome P-450.

Authors:  T R Tephly; P Hibbeln
Journal:  Biochem Biophys Res Commun       Date:  1971-02-19       Impact factor: 3.575

View more
  67 in total

Review 1.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

2.  Haem oxygenase: a model for therapeutic intervention.

Authors:  Gregory J Quinlan; Anna L Lagan; Timothy W Evans
Journal:  Intensive Care Med       Date:  2008-02-20       Impact factor: 17.440

3.  Stereospecific haem cleavage. A model for the formation of bile-pigment isomers in vivo and in vitro.

Authors:  S B Brown
Journal:  Biochem J       Date:  1976-10-01       Impact factor: 3.857

4.  The cytochrome P-450-depleted animal: an experimental model for in vivo studies in chemical biology.

Authors:  G S Drummond; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

5.  Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases.

Authors:  H M Schipper
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

6.  Formation of cobalt protoporphyrin in the liver of rats. A mechanism for the inhibition of liver haem biosynthesis by inorganic cobalt.

Authors:  P Sinclair; A H Gibbs; J F Sinclair; F de Matteis
Journal:  Biochem J       Date:  1979-03-15       Impact factor: 3.857

7.  Selenium regulation of hepatic heme metabolism: induction of delta-aminolevulinate synthase and heme oxygenase.

Authors:  M D Maines; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

8.  Cobalt inhibition of synthesis and induction of delta-aminolevulinate synthase in liver.

Authors:  M D Maines; V Janousĕk; J M Tomio; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

9.  Studies on the mechanism of induction of haem oxygenase by cobalt and other metal ions.

Authors:  M D Maines; A Kappas
Journal:  Biochem J       Date:  1976-01-15       Impact factor: 3.857

10.  Manganese and zinc blockade of enzyme induction: studies with microsomal heme oxygenase.

Authors:  G S Drummond; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.